本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Atrium Therapeutics

10.21
-0.1500-1.45%
盤後10.210.00000.00%16:10 EDT
成交量:25.57萬
成交額:267.06萬
市值:1.75億
市盈率:-2.65
高:10.71
開:10.37
低:10.15
收:10.36
52周最高:16.77
52周最低:10.00
股本:1,710.56萬
流通股本:1,572.10萬
量比:0.39
換手率:1.63%
股息:- -
股息率:- -
每股收益(TTM):-3.8578
每股收益(LYR):-3.1905
淨資產收益率:-43.98%
總資產收益率:-399.25%
市淨率:0.81
市盈率(LYR):-3.20

資料載入中...

2024/05/06

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/14

重要事件披露

Form 8-K - Current report
2023/12/13

重要事件披露

Form 8-K - Current report